Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing polyglutamate paclitaxel with docetaxel in progressing non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing polyglutamate paclitaxel plus carboplatin versus paclitaxel plus carboplatin in advanced or recurrent non-small cell…
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial update on postoperative radiotherapy for patients with IIIA (N2) non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC [Phase 1]
Phase 1 study evaluating the combination of necitumumab and pembrolizumab in stage IV non-small cell lung cancer has completed with results …
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial investigating carboplatin with paclitaxel poliglumex or paclitaxel in women with stage IIIB, stage IV, or recurrent non-small …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: 2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update evaluating erlotinib with or without chemotherapy in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel-carboplatin-bevacizumab with or without nitroglycerin in metastatic non-squamous non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2020-09-24Clinical Trial Update: Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer [NA]
Clinical trial investigating gene expression levels to predict treatment response in stage IV non-small cell lung cancer; study terminated w…
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment [Phase 2]
Phase 2 trial evaluating SHR1701 with radiotherapy in metastatic non-small cell lung cancer after failure of first-line treatment.
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC [Phase 3]
Phase 3 trial investigating BCD-100 (anti-PD-1) with platinum chemotherapy as first-line therapy for advanced non-squamous non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC [Phase 3]
Phase 3 trial evaluating nivolumab plus ipilimumab with chemotherapy versus chemotherapy alone as first-line treatment for non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases [Phase 2]
Phase 2 trial of cabozantinib in non-small cell lung cancer with brain metastases was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial updating safety, tolerability, pharmacokinetics, and anti-tumor activity of ASK120067 in locally advanced and metas…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer [Phase 2]
A phase 2 trial evaluating pemetrexed disodium with or without erlotinib hydrochloride in stage IIIB-IV or recurrent non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial investigating pegilodecakin (LY3500518) with nivolumab versus nivolumab alone as second-line therapy in metastatic non-small c…
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update for TQ-B3139 capsules in MET-altered advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial evaluating abemaciclib in combination with another anti-cancer drug in non-small cell lung cancer has completed with results p…
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: A Study of Combination Therapy in NSCLC [Phase 2]
A Phase 2 clinical trial update for a combination therapy in non-small cell lung cancer; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update investigating camrelizumab with apatinib as neoadjuvant therapy for resectable non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: A Study to Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLC [Phase 3]
Phase 3 trial comparing TRS003 to China-approved Bevacizumab in advanced non-squamous non-small-cell lung cancer to assess similarity in eff…
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the oral JAK inhibitor AZD4205 in combination with osimertinib in patients with advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC [Phase 2]
Phase 2 trial evaluating radiotherapy combined with albumin-bound paclitaxel and nedaplatin for locally advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Phase II Lung Metcore - Preoperative Metformin for Lung Cancer [Phase 2]
Phase II trial evaluating preoperative metformin for lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of chemotherapy and radiation therapy followed by surgery in stage IIB/IIIA non-small cell…
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: Efficacy and Safety of Platinum-based Chemotherapy + Bevacizumab + Durvalumab, and Salvage SBRT for IV Non-Small Cell Lung Cancer Patients With EGFR Mutations After Failure of First Line Osimertinib: A Multicenter, Prospective, Phase II Clinical Study [Phase 2]
A multicenter Phase II study evaluating platinum-based chemotherapy with bevacizumab and durvalumab, plus salvage SBRT, in stage IV EGFR-mut…